iDtheinvestordatabase
Home / Directory / LongeVC
Active: new fund Oct 2025 Verified 4 Nov 2026

LongeVC

Venture firm investing in early-stage biotech and longevity companies.

Type
VC firm
Location
Washington, District of Columbia, United States
Stages
Seed
Backs
Biotech and pharma, Medtech and digital health
Sectors
Biotech, Healthtech and life sciences, AI
Fund size / AUM
$11.5M LongeVC Fund II (Form D amount sold, 2025)
Latest fund or filing
25 Nov 2025
Portfolio mix
Biotech and pharma 61%; Medtech and digital health 17%; Consumer products 13%; B2B software 4%; Consumer apps 4% (n=23)

Fund filings (SEC Form D)

Latest fund on file
LongeVC Fund II
Filed
25 Nov 2025 (new notice)
Fund size
$12M (amount sold)
Fund vehicles filed in the last 12 months
1 (includes feeder and parallel vehicles)

See this fund's filings on SEC EDGAR

Contacts on file

For LongeVC, the paid file holds: 8 named decision-makers with roles; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

TrogenixRubedolifeUnnaturalproductsHelixnanoLongevitybiotech

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 24 lists